PSCHvsBBPETF Comparison
VS
Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 1 sector exposures: Healthcare. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.34% for BBP. PSCH is up 21.86% year-to-date (YTD) with +$7M in YTD flows. BBP performs better with 32.02% YTD performance, and +$50M in YTD flows. Run a side-by-side ETF comparison of PSCH and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PSCH vs BBP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/09/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH BBP | -2.89%+4.09% | +13.44%+23.23% | +21.86%+32.02% | +30.10%+49.71% | +36.07%+98.63% | -13.90%+100.65% |
| Flows | PSCH BBP | +$14M+$5M | +$25M+$20M | +$7M+$50M | +$2M+$62M | -$109M+$68M | -$207M+$61M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH BBP | +15.73%+25.85% | +19.67%+25.14% | +21.83%+24.72% | +22.87%+26.61% |
| Max drawdown | PSCH BBP | -4.27%-9.34% | -15.36%-9.59% | -22.80%-25.54% | -45.76%-37.61% |
| Max drawdown duration | PSCH BBP | 21d39d | 168d48d | 488d292d | 1766d586d |
Trading data
PSCH | BBP | |
Last sale 9/10/2026 at 1:30 PM | $53.11 | $103.47 |
| Previous close 09/09/2026 | $53.71 | $105.52 |
| Consolidated volume 09/09/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PSCH | BBP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/10/2026 at 1:30 PM
Live
Closed
PSCH | BBP | |
|---|---|---|
| Last price | $53.11 | $103.47 |
| 1D performance | -1.12% | -1.94% |
| AuM | $181.59 M | $115.83 M |
| E/R | 0.29% | 0.34% |
Characteristics
PSCH | BBP | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | VIRTUS Investment Partners |
| Benchmark | S&P SmallCap 600 Capped Health Care Index | LifeSci Biotechnology Products Index |
| N° of holdings | 69 | 66 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 7, 2010 | December 16, 2014 |
| ESG | No | No |
Advertisement
Exposure
Countries
PSCH
USA
95.04%
Other
4.96%
BBP
USA
86.5%
Other
13.5%
Sectors
PSCH
Healthcare
100%
Other
0%
BBP
Healthcare
98.2%
Other
1.8%
Advertisement
Diversification
PSCH
Total weight of top 15 holdings out of 15
48.1%
BBP
Total weight of top 15 holdings out of 15
26.78%
Top 15 holdings
Data as of July 31, 2026
PSCH
Glaukos Corp.
4.96%
Corcept Therapeutics, Inc.
4.64%
Alkermes Plc
4.21%
Protagonist Therapeutics, Inc.
4.20%
TG Therapeutics, Inc.
3.68%
PTC Therapeutics, Inc.
3.23%
Liquidia Corp.
3.19%
Teleflex, Inc.
3.11%
Ligand Pharmaceuticals, Inc.
3.01%
Indivior Pharmaceuticals, Inc.
2.55%
Merit Medical Systems, Inc.
2.52%
RadNet, Inc.
2.34%
Veracyte, Inc.
2.32%
ICU Medical, Inc.
2.17%
Concentra Group Holdings Parent, Inc.
1.96%
BBP
Crinetics Pharmaceuticals, Inc.
3.24%
Verastem, Inc.
1.98%
Nuvation Bio, Inc.
1.80%
Omeros Corp.
1.73%
Geron Corp.
1.72%
BridgeBio Pharma, Inc.
1.68%
Agios Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
BeOne Medicines Ltd.
1.64%
Kiniksa Pharmaceuticals International Plc
1.63%
Precigen, Inc.
1.62%
Xeris Biopharma Holdings, Inc.
1.61%
ACADIA Pharmaceuticals, Inc.
1.60%
Iovance Biotherapeutics, Inc.
1.60%
Rhythm Pharmaceuticals, Inc.
1.60%
Frequently asked questions about PSCH and BBP
How have the PSCH and BBP ETFs performed in 2026?
As of September 9, 2026, PSCH is up 21.86% year-to-date (YTD), while BBP has returned 32.02%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: PSCH or BBP?
Year-to-date, the PSCH ETF saw +$7M in flows, compared to +$50M for BBP.
Which ETF is more volatile: PSCH or BBP?
Over the past year, PSCH had a volatility of 19.67%, while BBP experienced 25.14%.
Which ETF is bigger: PSCH or BBP?
As of September 9, 2026, PSCH holds $181.59 M in assets under management (AUM), while BBP manages $115.83 M.
What sectors do the PSCH and BBP ETFs invest in?
PSCH leans toward sectors like Healthcare. Meanwhile, BBP focuses on Healthcare.
What are the top holdings of the PSCH ETF and BBP ETF?
PSCH top holdings include Glaukos Corp., Corcept Therapeutics, Inc. and Alkermes Plc. BBP holds in its top three: Crinetics Pharmaceuticals, Inc., Verastem, Inc. and Nuvation Bio, Inc..
Which ETF is more diversified: PSCH or BBP?
PSCH holds 69 securities with 48.1% of its assets in the top 15. BBP has 66 securities and a top 15 weight of 26.78%.
Advertisement
Advertisement
